BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2653118)

  • 21. The effects of norepinephrine infusion on oxygen consumption in a patient with septic shock.
    Bouffard Y; Tissot S; Viale JP; Delafosse B; Annat G; Bachmann P; Motin J
    Intensive Care Med; 1990; 16(2):133-4. PubMed ID: 2332540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressor dosing in septic shock.
    Alaniz C; Pollard S
    Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
    [No Abstract]   [Full Text] [Related]  

  • 23. Norepinephrine therapy in septic shock.
    Cohen IL; Fein IA
    Crit Care Med; 1988 Feb; 16(2):206-7. PubMed ID: 3342633
    [No Abstract]   [Full Text] [Related]  

  • 24. Norepinephrine in septic shock: renewed interest in an old drug.
    Dasta JF
    DICP; 1990 Feb; 24(2):153-6. PubMed ID: 2408258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating septic shock with norepinephrine.
    Groeneveld AB; Girbes AR; Thijs LG
    Crit Care Med; 1999 Sep; 27(9):2022-3. PubMed ID: 10507635
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic effects of dobutamine in hyperkinetic septic shock treated with norepinephrine].
    Lejus C; Blanloeil Y; François T; Michel P; Pinaud M; Desjars P
    Ann Fr Anesth Reanim; 1991; 10(1):31-7. PubMed ID: 2008972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine versus norepinephrine: is one better?
    Vincent JL; Biston P; Devriendt J; Brasseur A; De Backer D
    Minerva Anestesiol; 2009 May; 75(5):333-7. PubMed ID: 19412154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norepinephrine therapy has no deleterious renal effects in human septic shock.
    Desjars P; Pinaud M; Bugnon D; Tasseau F
    Crit Care Med; 1989 May; 17(5):426-9. PubMed ID: 2520533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 31. The authors reply.
    Annane D; Dellinger RP
    Crit Care Med; 2013 Dec; 41(12):e484. PubMed ID: 24275413
    [No Abstract]   [Full Text] [Related]  

  • 32. Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock.
    Reithmann C; Hallström S; Pilz G; Kapsner T; Schlag G; Werdan K
    Circ Shock; 1993 Sep; 41(1):48-59. PubMed ID: 8403246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal adrenergic support in septic shock due to peritonitis.
    Sun Q; Tu Z; Lobo S; Dimopoulos G; Nagy N; Rogiers P; De Backer D; Vincent JL
    Anesthesiology; 2003 Apr; 98(4):888-96. PubMed ID: 12657850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypotension in septic shock.
    Pastor CM; Morel DR
    Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of dopamine in the treatment of shock states].
    Wattel F; Chopin C; Gosselin B; Durocher A; Vallet D; Stevigny R; Ramon P; Berzin B
    Anesth Analg (Paris); 1976; 33(3):355-74. PubMed ID: 1015658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states.
    Redl-Wenzl EM; Armbruster C; Edelmann G; Fischl E; Kolacny M; Wechsler-Fördös A; Sporn P
    Intensive Care Med; 1993; 19(3):151-4. PubMed ID: 8315122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current therapy of shock.
    Goldberg LI; Talley RC
    Adv Intern Med; 1971; 17():363-78. PubMed ID: 4147306
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noradrenaline as a vasoactive agent in septic shock.
    Tordoff SG; Thompson JL; Williams AW
    Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.